These data suggest that BIN1 has a novel role in regulating the GTPase activity of dynamin 2 and that dysregulation arising in CNM patients with dynamin 2 mutations is due to constitutively active GTPase activity, enhanced membrane fission, and consequential myocyte dysfunction that is tightly linked to the pathogenesis of CNM. Here, BIN1 is linked to centronuclear myopathy.